Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors

被引:40
作者
Huiss, S
Damien, B
Schneider, F
Muller, CP
机构
[1] LAB NATL SANTE,DEPT IMMUNOL,L-1011 LUXEMBOURG,LUXEMBOURG
[2] LAB NATL SANTE,DEPT MICROBIOL,L-1011 LUXEMBOURG,LUXEMBOURG
[3] UNIV TUBINGEN,FAC MED,TUBINGEN,GERMANY
关键词
measles; secondary immune response; immunoglobulin subclasses;
D O I
10.1046/j.1365-2249.1997.00137.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among 44 fully protected, late convalescent adults re-exposed to measles, four developed an asymptomatic secondary immune response (SLR) with a significant increase in measles virus (MV)-specific IgG and low IgM. The boosted antibodies were mainly of the IgG1 subclass and reacted with the nucleoprotein and the haemagglutinin protein. About 30 weeks after re-exposure, antibody levels had decreased by 35-50%, suggesting that the booster effect may only be transient. SLR was only found in individuals with a pre-exposure IgG level below a well defined threshold. Antibody levels above this threshold fully protected against SIR. SIR seems to be an 'all or none response' where the magnitude of increase in specific IgG is independent of pre-exposure antibody levels as long as these are below the above threshold. In combination with pre-exposure neutralizing and haemagglutination inhibiting titres, a threshold was defined below which SIR is Likely to occur. This may be useful to predict susceptibility to SIR in a given population, since individuals undergoing clinically inapparent SIR are among seropositive subjects, the most likely candidates to support transmission of virus.
引用
收藏
页码:416 / 420
页数:5
相关论文
共 23 条
  • [1] VACCINATED CHILDREN GET MILDER MEASLES INFECTION - A COMMUNITY STUDY FROM GUINEA-BISSAU
    AABY, P
    BUKH, J
    LEERHOY, J
    LISSE, IM
    MORDHORST, CH
    PEDERSEN, IR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (05) : 858 - 863
  • [2] [Anonymous], 1940, OBSERVATIONS MADE EP
  • [3] Center for Disease Control, 1990, MMWR-MORBID MORTAL W, V39, P13
  • [4] MEASLES ANTIBODY - COMPARISON OF LONG-TERM VACCINATION TITERS, EARLY VACCINATION TITERS AND NATURALLY ACQUIRED-IMMUNITY TO AND BOOSTER EFFECTS ON THE MEASLES-VIRUS
    CHRISTENSON, B
    BOTTIGER, M
    [J]. VACCINE, 1994, 12 (02) : 129 - 133
  • [5] MILD MEASLES AND SECONDARY VACCINE FAILURE DURING A SUSTAINED OUTBREAK IN A HIGHLY VACCINATED POPULATION
    EDMONSON, MB
    ADDISS, DG
    MCPHERSON, JT
    BERG, JL
    CIRCO, SR
    DAVIS, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (18): : 2467 - 2471
  • [6] MAJOR IMPEDIMENTS TO MEASLES ELIMINATION - THE MODERN EPIDEMIOLOGY OF AN ANCIENT DISEASE
    FRANK, JA
    ORENSTEIN, WA
    BART, KJ
    BART, SW
    ELTANTAWY, N
    DAVIS, RM
    HINMAN, AR
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (09): : 881 - 888
  • [7] MEASLES OUTBREAK IN A FULLY IMMUNIZED SECONDARY-SCHOOL POPULATION
    GUSTAFSON, TL
    LIEVENS, AW
    BRUNELL, PA
    MOELLENBERG, RG
    BUTTERY, CMG
    SEHULSTER, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) : 771 - 774
  • [8] Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus
    Hayney, MS
    Poland, GA
    Dimanlig, P
    Schaid, DJ
    Jacobson, RM
    Lipsky, JJ
    [J]. VACCINE, 1997, 15 (01) : 3 - 6
  • [9] KRUGMAN S, 1983, REV INFECT DIS, V5, P477
  • [10] PERSISTENCE OF MEASLES ANTIBODY AFTER REVACCINATION
    MARKOWITZ, LE
    ALBRECHT, P
    ORENSTEIN, WA
    LETT, SM
    PUGLIESE, TJ
    FARRELL, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) : 205 - 208